Establishment Labs Executive and Leadership Team

Peter Caldini, the Chief Executive Officer at Establishment Labs, directs the company's overarching strategy and operational execution. Caldini guides the organization's mission to enhance women's health and wellness through advanced Femtech solutions. This leadership involves aligning all departments toward the development and global distribution of innovative products like the Motiva Flora® tissue expander and Mia Femtech. Caldini ensures that the company's scientific and engineering endeavors translate into tangible improvements in patient outcomes, particularly in breast reconstruction and aesthetics. The Chief Executive Officer oversees the integration of market insights with research and development efforts, fostering a culture of continuous improvement and expansion. By focusing on strategic partnerships and market penetration, Peter Caldini drives the company's growth and solidifies its position as a leader in the medical technology sector, ensuring robust financial performance and sustained innovation.

Juan Chacón-Quirós, the Founder & Chief Executive Officer at Establishment Labs, established the company's vision for transforming women's health through innovative medical technology. Chacón-Quirós champions the development of groundbreaking Femtech solutions, focusing on breast health, aesthetics, and reconstruction. The Founder & Chief Executive Officer oversees the strategic direction of product innovation, ensuring that scientific advancements and engineering excellence are at the forefront of the company's offerings. This includes guiding the expansion of the Motiva Flora® tissue expander and Mia Femtech platforms globally. Juan Chacón-Quirós fosters a culture of pioneering research, supported by extensive patent applications and peer-reviewed studies, to maintain Establishment Labs' competitive edge. The Founder & Chief Executive Officer's leadership ensures the company's commitment to improving patient outcomes and advancing the standard of care in women's wellness worldwide, driving significant market impact and establishing a legacy of innovation.

Sandra Harris, the Chief Financial Officer at Establishment Labs, directs the company's financial strategy, planning, and reporting. Harris oversees all fiscal operations, ensuring financial health and supporting the company's growth initiatives in the global medical technology market. The Chief Financial Officer manages capital allocation, investment strategies, and financial risk management, crucial for funding research, development, and the international expansion of Femtech solutions. Sandra Harris plays a key role in maintaining investor relations and ensuring compliance with financial regulations, supporting the NASDAQ listing. The Chief Financial Officer's leadership ensures that financial resources are effectively deployed to advance women's health and wellness through innovations like the Motiva Flora® tissue expander and Mia Femtech. By providing critical financial insights, Sandra Harris enables strategic decision-making that drives profitability and long-term value for Establishment Labs.

Roberto De Mezerville, the Chief Technology Officer at Establishment Labs, architects the company's technological roadmap and drives innovation in Femtech solutions. De Mezerville leads the research and development teams, focusing on engineering advancements for breast health, aesthetics, and reconstruction. The Chief Technology Officer oversees the integration of cutting-edge science and technology into products such as the Motiva Flora® tissue expander and Mia Femtech. This involves managing the company's extensive patent portfolio and ensuring that technological development aligns with market needs and regulatory requirements. Roberto De Mezerville's expertise is critical in translating complex scientific concepts into market-ready medical devices that improve patient outcomes. The Chief Technology Officer ensures the scalability and reliability of the company's technological infrastructure, supporting global operations and the continuous enhancement of product performance and safety, thereby reinforcing Establishment Labs' commitment to scientific excellence.

Ross Mansbach, the Chief Compliance Officer & General Counsel at Establishment Labs, oversees the company's legal affairs and ensures adherence to all regulatory and ethical standards. Mansbach guides the legal framework supporting the development and global distribution of advanced Femtech solutions for women's health. The Chief Compliance Officer & General Counsel manages all aspects of corporate governance, intellectual property protection, and risk mitigation, particularly concerning medical device regulations worldwide. Ross Mansbach's role is vital in safeguarding the company's operations and reputation as it expands its portfolio, including the Motiva Flora® tissue expander and Mia Femtech. The Chief Compliance Officer & General Counsel ensures that all business practices align with legal requirements and the company's commitment to patient safety and product integrity. By providing expert legal counsel, Ross Mansbach supports strategic initiatives and fosters a culture of compliance across Establishment Labs.